Prospective Registry of Histotripsy for Soft Tissue Tumors

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07470008
Status
Recruiting
Apply to this trial

Conditions

  • Soft Tissue Cancer
  • Soft Tissue Lesion
  • Soft Tissue Neoplasm

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Medical Record Review — OTHER
    Data will be collected from the participants medical records.

Study Details

Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.

Key Dates

Start date
Jan 29, 2026
Status verified
Mar 2026
Primary completion
Aug 8, 2030
Completion
Aug 8, 2031

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Participants with Soft Tissue Tumors
    Participant data will be collected from participants' medical records. Cancer history, laboratory analysis, histotripsy procedure details, adverse events, and oncological outcomes of the procedure along with demographic data will be collected.

Primary Outcome Measure

Frequency of overall tumor response across all participants [ Time Frame: up to 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94143
Ryan Lokken, MD
[email protected]
877-827-3222
Ryan Lokken, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

By research site
University of California, San Francisco· San Francisco, CA

Related Studies